Company Update (NYSE:BSX): Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM™ S-ICD System

[PR Newswire] – MARLBOROUGH, Mass., March 17, 2015 /PRNewswire/ — Boston Scientific Corporation (BSX) has received FDA and CE Mark approval of the EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) System. The EMBLEM S-ICD System . . . → Read More: Company Update (NYSE:BSX): Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM™ S-ICD System Similar Articles: Market Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Maple Grove Operations Named A 2014 "Best Plants" Winner Stock Update (NYSE:BSX): Boston Scientific To Host And Webcast Investor Day Business Review May 1, 2015 Market Update (NYSE:BSX): Boston Scientific To Participate In 2014 Stifel Healthcare Conference